Splash
Splash

Past Events

Past Events

14 September 2020 22:00 BST 17:00 EDT
H.C. Wainwright 22nd Annual Global Investment Virtual Conference
14 August 2020 14:00 BST 09:00 EDT
Verona Pharma Second Quarter 2020 Financial Results and Conference Call

To participate, please dial one of the following numbers and reference conference ID 4180419:

877-870-9135 for callers in the United States
+44 800 279 6619 for international callers

13 August 2020 21:30 BST 16:30 EDT
Canaccord Genuity 40th Annual Growth Conference
12 August 2020 16:30 BST 11:30 EDT
2020 Wedbush PacGrow Healthcare Virtual Conference
10 August 2020 19:30 BST 14:30 EDT
BTIG Virtual Biotechnology Conference 2020
1 June 2020 12:30 BST 07:30 EDT
Investor and Analyst KOL Webcast

To participate, please dial one of the following numbers and reference conference ID 6954635:

877-870-9135 for callers in the United States
0207 192 8338 for callers in the United Kingdom
0800 723 4756 for callers in Germany

30 April 2020 14:00 BST 09:00 EDT
Verona Pharma First Quarter 2020 Financial Results and Conference Call

To participate, please dial one of the following numbers and reference conference ID 2667888:

866-940-4574 for callers in the United States
0800 028 8438 for callers in the United Kingdom
0800 181 5287 for callers in Germany

16 April 2020 10:30 BST 05:30 EDT
Annual General Meeting 2020
27 February 2020 14:00 BST 09:00 EDT
Verona Pharma Full Year 2019 Financial Results and Conference Call

Conference call time: 9.00 am EST / 2.00 pm GMT.

To participate, please dial one of the following numbers and reference conference ID 5394158:

  • 866-940-4574 for callers in the United States
  • 0800 028 8438 for callers in the United Kingdom
  • 0800 181 5287 for callers in Germany
4 February 2020 13:45 BST 08:45 EDT
LSX World Congress 2020
13 January 2020 14:00 BST 09:00 EDT
Verona Pharma to Report 4 Week Phase 2b COPD Study Results with Nebulized Ensifentrine on Top of Tiotropium Therapy
20 November 2019 17:20 BST 12:20 EDT
Jefferies 2019 London Healthcare Conference
19 November 2019 13:00 BST 08:00 EDT
Stifel 2019 Healthcare Conference
Presenter: Jan-Anders Karlsson, CEO
18 November 2019 05:00 BST 00:00 EDT
Guggenheim Healthcare Talks Idea Forum | Neuro/Immunology Day
5 November 2019 13:00 BST 08:00 EDT
Verona Pharma Third Quarter 2019 Financial Results and Conference Call

To participate, please dial one of the following numbers and reference conference ID 6498479:

866-940-4574 for callers in the United States
0800 028 8438 for callers in the United Kingdom
0800 181 5287 for callers in Germany

10 September 2019 20:00 BST 15:00 EDT
2019 H.C. Wainwright 21st Annual Global Investment Conference
13 August 2019 18:55 BST 13:55 EDT
2019 Wedbush PacGrow Healthcare Conference

Supporting materials

Wedbush Presentation

12 August 2019 05:00 BST 00:00 EDT
BTIG Biotechnology Conference 2019
6 August 2019 13:00 BST 08:00 EDT
Verona Pharma Second Quarter 2019 Financial Results and Conference Call
5 August 2019 13:00 BST 08:00 EDT
Ensifentrine (RPL554) Positive Data from 7-Day Phase 2 Clinical Trial in COPD Patients with Dry Powder Inhaler Formulation
5 June 2019 13:30 BST 08:30 EDT
Jefferies 2019 Global Healthcare Conference

Jan-Anders Karlsson, Chief Executive Officer and Executive Director

20 May 2019 05:00 BST 00:00 EDT
Expanded Analysis of Clinical Data at ATS 2019
8 May 2019 05:00 BST 00:00 EDT
Investor & Analyst R&D Forum London 2019
7 May 2019 13:00 BST 08:00 EDT
Verona Pharma First Quarter 2019 Financial Results and Conference Call
7 May 2019 10:00 BST 05:00 EDT
Annual General Meeting of Shareholders
Click here for more information
8 April 2019 17:30 BST 12:30 EDT
H.C Wainwright Global Life Sciences Conference
13 March 2019 14:00 BST 10:00 EDT
Cowen and Company 39th Annual Health Care Conference

Supporting materials

Cowen presentation

12 March 2019 13:00 BST 09:00 EDT
Verona Pharma presents at Ligand Pharmaceuticals Analyst Day

Supporting materials

Ligand presentation

26 February 2019 13:00 BST 08:00 EDT
Verona Pharma Full Year 2018 Financial Results and Conference Call
14 January 2019 13:00 BST 08:00 EDT
Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance Treatment
7 January 2019 23:23 BST 18:23 EDT
JP Morgan Conference

Supporting materials

JP Morgan Conference

21 December 2018 17:35 BST 12:35 EDT
Citi Healthcare Conference
13 November 2018 13:45 BST 08:45 EDT
Verona Pharma to Present at Stifel 2018 Healthcare Conference
6 November 2018 13:00 BST 08:00 EDT
Verona Pharma Third Quarter 2018 Financial Results and Conference Call
12 October 2018 16:00 BST 11:00 EDT
Investor & Analyst R&D Forum
18 September 2018 13:00 BST 08:00 EDT
Verona Pharma Presents Expanded Dataset from RPL554 Phase 2b Clinical Trial in COPD Presented at European Respiratory Society International Congress
Splash

© Verona Pharma plc 2020. All rights reserved